Veeva Systems Inc. (VEEV) EV/Sales Ratio: 7.65x
Is Veeva Systems Inc.’s EV/Sales ratio high or low?
Veeva Systems Inc.'s EV/Sales ratio of 7.65x is 51% below its 5-year average of 15.70x, near the low end of its 5-year range (7.56x–34.70x).
As of Thursday, June 11, 2026. 38.82% below its 12-month average of 12.50x.
VEEV EV/Sales Ratio Chart
VEEV Average EV/Sales Ratio Chart
VEEV Current vs Average EV/Sales Ratio Chart
VEEV EV/Sales Ratio Metrics
EV/SALES RATIO
7.65x
EV/SALES RATIO AVG TTM
12.50x
EV/SALES RATIO AVG 3Y
13.33x
EV/SALES RATIO AVG 5Y
15.70x
EV/SALES RATIO AVG 10Y
18.44x
EV/SALES RATIO AVG 15Y
17.53x
EV/SALES RATIO AVG 20Y
17.53x
CURRENT VS TTM AVG
-38.82%
CURRENT VS 3Y AVG
-42.60%
CURRENT VS 5Y AVG
-51.27%
CURRENT VS 10Y AVG
-58.52%
CURRENT VS 15Y AVG
-56.35%
CURRENT VS 20Y AVG
-56.35%
VEEV Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veeva Systems Inc. (VEEV) | $26.31B | 7.65x | 12.50x | 13.33x | 15.70x |
| DexCom, Inc. (DXCM) | $28.92B | 6.18x | 6.63x | 10.22x | 13.87x |
| Biogen Inc. (BIIB) | $28.94B | 3.26x | 2.79x | 3.30x | 3.58x |
| Waters Corporation (WAT) | $23.21B | 9.27x | 7.03x | 7.13x | 7.32x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 6.13x | 7.35x | 7.51x | 8.18x |
| IQVIA Holdings Inc. (IQV) | $30.08B | 1.85x | 2.83x | 3.22x | 3.53x |
| BioNTech SE (BNTX) | $22.39B | 3.24x | 4.19x | 3.71x | 3.49x |
| Medline Inc. (MDLN) | $30.90B | 1.39x | 1.60x | 1.60x | 1.60x |
| Centene Corporation (CNC) | $32.26B | 0.14x | 0.11x | 0.20x | 0.29x |
| Moderna, Inc. (MRNA) | $18.71B | 8.10x | 5.96x | 5.02x | 6.82x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Veeva Systems Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Veeva Systems Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The EV/Sales ratio for VEEV stock is 7.65x.
- Is Veeva Systems Inc.'s EV/Sales ratio high or low?
- Veeva Systems Inc.'s EV/Sales ratio of 7.65x is 51% below its 5-year average of 15.70x, near the low end of its 5-year range (7.56x–34.70x).
- What is the TTM average EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The TTM average EV/Sales ratio for VEEV stock is 12.50x.
- What is the 3Y average EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The 3Y average EV/Sales ratio for VEEV stock is 13.33x.
- What is the 5Y average EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The 5Y average EV/Sales ratio for VEEV stock is 15.70x.
- What is the 10Y average EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The 10Y average EV/Sales ratio for VEEV stock is 18.44x.
- What is the 15Y average EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The 15Y average EV/Sales ratio for VEEV stock is 17.53x.
- What is the 20Y average EV/Sales ratio for Veeva Systems Inc. (VEEV)?
- The 20Y average EV/Sales ratio for VEEV stock is 17.53x.
Veeva Systems Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-10 | 7.65x |
| 2026-06-09 | 7.85x |
| 2026-06-08 | 7.82x |
| 2026-06-05 | 8.09x |
| 2026-06-04 | 8.99x |
| 2026-06-03 | 9.00x |
| 2026-06-02 | 9.22x |
| 2026-06-01 | 9.52x |
| 2026-05-29 | 8.77x |
| 2026-05-28 | 8.24x |
| 2026-05-27 | 7.93x |
| 2026-05-26 | 7.93x |
| 2026-05-22 | 8.02x |
| 2026-05-21 | 7.92x |
| 2026-05-20 | 8.27x |
| 2026-05-19 | 8.18x |
| 2026-05-18 | 8.21x |
| 2026-05-15 | 7.95x |
| 2026-05-14 | 7.81x |
| 2026-05-13 | 7.79x |
| 2026-05-12 | 7.98x |
| 2026-05-11 | 7.98x |
| 2026-05-08 | 8.34x |
| 2026-05-07 | 8.45x |
| 2026-05-06 | 8.40x |
| 2026-05-05 | 8.60x |
| 2026-05-04 | 8.55x |
| 2026-05-01 | 8.62x |
| 2026-04-30 | 7.80x |
| 2026-04-29 | 7.92x |
| 2026-04-28 | 7.93x |
| 2026-04-27 | 8.03x |
| 2026-04-24 | 8.07x |
| 2026-04-23 | 7.81x |
| 2026-04-22 | 8.21x |
| 2026-04-21 | 8.42x |
| 2026-04-20 | 8.48x |
| 2026-04-17 | 8.43x |
| 2026-04-16 | 8.42x |
| 2026-04-15 | 8.40x |
| 2026-04-14 | 7.96x |
| 2026-04-13 | 7.93x |
| 2026-04-10 | 7.56x |
| 2026-04-09 | 7.86x |
| 2026-04-08 | 8.36x |
| 2026-04-07 | 8.67x |
| 2026-04-06 | 8.78x |
| 2026-04-02 | 8.75x |
| 2026-04-01 | 8.68x |
| 2026-03-31 | 8.84x |
| 2026-03-30 | 8.85x |
| 2026-03-27 | 8.67x |
| 2026-03-26 | 8.97x |
| 2026-03-25 | 8.96x |
| 2026-03-24 | 9.02x |
| 2026-03-23 | 9.34x |
| 2026-03-20 | 9.28x |
| 2026-03-19 | 9.61x |
| 2026-03-18 | 9.52x |
| 2026-03-17 | 9.67x |
| 2026-03-16 | 9.59x |
| 2026-03-13 | 9.24x |
| 2026-03-12 | 9.35x |
| 2026-03-11 | 9.69x |
| 2026-03-10 | 9.83x |
| 2026-03-09 | 10.15x |
| 2026-03-06 | 10.15x |
| 2026-03-05 | 10.17x |
| 2026-03-04 | 9.77x |
| 2026-03-03 | 9.63x |
| 2026-03-02 | 9.38x |
| 2026-02-27 | 9.41x |
| 2026-02-26 | 9.46x |
| 2026-02-25 | 9.11x |
| 2026-02-24 | 9.08x |
| 2026-02-23 | 8.88x |
| 2026-02-20 | 9.32x |
| 2026-02-19 | 9.44x |
| 2026-02-18 | 9.37x |
| 2026-02-17 | 9.13x |
| 2026-02-13 | 8.98x |
| 2026-02-12 | 8.87x |
| 2026-02-11 | 9.14x |
| 2026-02-10 | 9.69x |
| 2026-02-09 | 9.56x |
| 2026-02-06 | 9.50x |
| 2026-02-05 | 9.51x |
| 2026-02-04 | 9.89x |
| 2026-02-03 | 9.89x |
| 2026-02-02 | 10.58x |
| 2026-01-30 | 10.61x |
| 2026-01-29 | 10.94x |
| 2026-01-28 | 11.38x |
| 2026-01-27 | 11.37x |
| 2026-01-26 | 11.71x |
| 2026-01-23 | 11.59x |
| 2026-01-22 | 11.77x |
| 2026-01-21 | 11.47x |
| 2026-01-20 | 11.28x |
| 2026-01-16 | 11.61x |
| 2026-01-15 | 11.43x |
| 2026-01-14 | 11.42x |
| 2026-01-13 | 11.95x |
| 2026-01-12 | 12.21x |
| 2026-01-09 | 12.58x |
| 2026-01-08 | 12.64x |
| 2026-01-07 | 12.54x |
| 2026-01-06 | 12.46x |
| 2026-01-05 | 11.56x |
| 2026-01-02 | 11.46x |
| 2025-12-31 | 11.66x |
| 2025-12-30 | 11.74x |
| 2025-12-29 | 11.76x |
| 2025-12-26 | 11.74x |
| 2025-12-24 | 11.66x |
| 2025-12-23 | 11.72x |
| 2025-12-22 | 11.67x |
| 2025-12-19 | 11.59x |
| 2025-12-18 | 11.38x |
| 2025-12-17 | 11.24x |
| 2025-12-16 | 11.45x |
| 2025-12-15 | 11.49x |
| 2025-12-12 | 11.66x |
| 2025-12-11 | 12.00x |
| 2025-12-10 | 11.99x |
| 2025-12-09 | 12.14x |
| 2025-12-08 | 12.52x |
| 2025-12-05 | 12.69x |
| 2025-12-04 | 12.70x |
| 2025-12-03 | 12.65x |
| 2025-12-02 | 12.58x |
| 2025-12-01 | 12.60x |
| 2025-11-28 | 12.59x |
| 2025-11-26 | 12.61x |
| 2025-11-25 | 12.57x |
| 2025-11-24 | 12.34x |
| 2025-11-21 | 12.80x |
| 2025-11-20 | 14.62x |
| 2025-11-19 | 14.76x |
| 2025-11-18 | 14.80x |
| 2025-11-17 | 14.99x |
| 2025-11-14 | 15.91x |
| 2025-11-13 | 15.82x |
| 2025-11-12 | 16.11x |
| 2025-11-11 | 16.23x |
| 2025-11-10 | 16.05x |
| 2025-11-07 | 16.00x |
| 2025-11-06 | 15.79x |
| 2025-11-05 | 16.02x |
| 2025-11-04 | 15.92x |
| 2025-11-03 | 15.87x |
| 2025-10-31 | 15.79x |
| 2025-10-30 | 15.44x |
| 2025-10-29 | 15.53x |
| 2025-10-28 | 15.80x |
| 2025-10-27 | 16.04x |
| 2025-10-24 | 15.89x |
| 2025-10-23 | 15.81x |
| 2025-10-22 | 15.72x |
| 2025-10-21 | 15.71x |
| 2025-10-20 | 15.49x |
| 2025-10-17 | 15.37x |
| 2025-10-16 | 15.88x |
| 2025-10-15 | 15.57x |
| 2025-10-14 | 15.59x |
| 2025-10-13 | 15.50x |
| 2025-10-10 | 15.53x |
| 2025-10-09 | 16.20x |
| 2025-10-08 | 16.39x |
| 2025-10-07 | 16.64x |
| 2025-10-06 | 16.27x |
| 2025-10-03 | 16.08x |
| 2025-10-02 | 16.33x |
| 2025-10-01 | 15.90x |
| 2025-09-30 | 16.17x |
| 2025-09-29 | 15.89x |
| 2025-09-26 | 15.74x |
| 2025-09-25 | 15.15x |
| 2025-09-24 | 15.04x |
| 2025-09-23 | 15.09x |
| 2025-09-22 | 15.22x |
| 2025-09-19 | 15.03x |
| 2025-09-18 | 15.11x |
| 2025-09-17 | 14.85x |
| 2025-09-16 | 14.81x |
| 2025-09-15 | 14.95x |
| 2025-09-12 | 14.96x |
| 2025-09-11 | 15.13x |
| 2025-09-10 | 14.85x |
| 2025-09-09 | 15.31x |
| 2025-09-08 | 15.31x |
| 2025-09-05 | 14.76x |
| 2025-09-04 | 14.60x |
| 2025-09-03 | 14.65x |
| 2025-09-02 | 14.59x |
| 2025-08-29 | 14.55x |
| 2025-08-28 | 15.19x |
| 2025-08-27 | 16.43x |
| 2025-08-26 | 16.02x |
| 2025-08-25 | 15.94x |
| 2025-08-22 | 16.27x |
| 2025-08-21 | 15.77x |
| 2025-08-20 | 15.87x |
| 2025-08-19 | 15.89x |
| 2025-08-18 | 15.76x |
| 2025-08-15 | 15.68x |
| 2025-08-14 | 15.35x |
| 2025-08-13 | 15.59x |
| 2025-08-12 | 15.37x |
| 2025-08-11 | 15.46x |
| 2025-08-08 | 15.76x |
| 2025-08-07 | 15.63x |
| 2025-08-06 | 15.79x |
| 2025-08-05 | 15.72x |
| 2025-08-04 | 15.95x |
| 2025-08-01 | 15.72x |
| 2025-07-31 | 15.88x |
| 2025-07-30 | 16.04x |
| 2025-07-29 | 16.06x |
| 2025-07-28 | 16.37x |
| 2025-07-25 | 16.25x |
| 2025-07-24 | 16.29x |
| 2025-07-23 | 15.99x |
| 2025-07-22 | 15.94x |
| 2025-07-21 | 15.70x |
| 2025-07-18 | 15.77x |
| 2025-07-17 | 15.43x |
| 2025-07-16 | 15.78x |
| 2025-07-15 | 15.60x |
| 2025-07-14 | 15.77x |
| 2025-07-11 | 15.40x |
| 2025-07-10 | 15.74x |
| 2025-07-09 | 15.89x |
| 2025-07-08 | 15.68x |
| 2025-07-07 | 15.70x |
| 2025-07-03 | 15.89x |
| 2025-07-02 | 15.79x |
| 2025-07-01 | 15.81x |
| 2025-06-30 | 16.10x |
| 2025-06-27 | 15.84x |
| 2025-06-26 | 15.71x |
| 2025-06-25 | 15.61x |
| 2025-06-24 | 15.73x |
| 2025-06-23 | 15.66x |
| 2025-06-20 | 15.64x |
| 2025-06-18 | 15.72x |
| 2025-06-17 | 15.75x |
| 2025-06-16 | 15.91x |
| 2025-06-13 | 15.79x |
| 2025-06-12 | 15.77x |
| 2025-06-11 | 16.14x |
| 2025-06-10 | 15.88x |
| 2025-06-09 | 15.83x |
| 2025-06-06 | 15.95x |
| 2025-06-05 | 16.22x |
| 2025-06-04 | 15.85x |
| 2025-06-03 | 15.92x |
| 2025-06-02 | 15.56x |
| 2025-05-30 | 16.49x |
| 2025-05-29 | 16.45x |
Showing the most recent 260 of 3,181 data points. The chart above shows the full history.
Related Metrics
About Veeva Systems Inc.
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Peter Gassner